These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5054587)

  • 1. The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin.
    Shoeman DW; Azarnoff DL
    Pharmacology; 1972; 7(3):169-77. PubMed ID: 5054587
    [No Abstract]   [Full Text] [Related]  

  • 2. The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin.
    Shoeman DW; Benjamin DM; Azarnoff DL
    Ann N Y Acad Sci; 1973 Nov; 226():127-30. PubMed ID: 4520391
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA; Evenson MA; Sarver KP; Wagnild JP
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of digitoxin and some related cardenolides to human plasma proteins.
    Lukas DS; De Martino AG
    J Clin Invest; 1969 Jun; 48(6):1041-53. PubMed ID: 5771186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of digitoxin, valproate and phenytoin in sera from diabetics.
    Doucet J; Fresel J; Hue G; Moore N
    Eur J Clin Pharmacol; 1993; 45(6):577-9. PubMed ID: 8157046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1975 Aug; 8(6):445-53. PubMed ID: 1233247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.
    Reidenberg MM; Odar-Cederlöf I; von Bahr C; Borgå O; Sjöqvist F
    N Engl J Med; 1971 Jul; 285(5):264-7. PubMed ID: 4378402
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum digitoxin in uremic patients.
    Shoeman DW; Azarnoff DL
    Clin Pharmacol Ther; 1972; 13(3):460. PubMed ID: 5026385
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of disease states on plasma protein binding of drugs.
    Reidenberg MM
    Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate plasma protein binding in the uremic condition.
    Brewster D; Muir NC
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin.
    Storstein L
    Clin Pharmacol Ther; 1976 Jul; 20(1):6-14. PubMed ID: 776491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uraemic and normal plasma protein binding of various cardiac glycosides under "in vivo" conditions.
    Kramer P; Köthe E; Scheler F
    Eur J Clin Invest; 1974 Feb; 4(1):53-8. PubMed ID: 4819835
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered protein binding of diphenylhydantoin in uremic plasma.
    Blum MR; Riegelman S; Becker CE
    N Engl J Med; 1972 Jan; 286(2):109. PubMed ID: 5006870
    [No Abstract]   [Full Text] [Related]  

  • 18. The binding of gitoxin to human plasma proteins.
    Verbeke N; Pellegrin P; Vienne A; Lesne M
    Eur J Clin Pharmacol; 1979 Nov; 16(5):341-4. PubMed ID: 520402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.
    Odar-Cederlöf I; Borgå O
    Eur J Clin Pharmacol; 1974; 7(1):31-7. PubMed ID: 4852619
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.